Welcome to the e-CCO Library!

P706: A distinct subset of tissue-resident Th17 cells expands in the inflamed intestines of Crohn’s Disease patients and responds to colitogenic bacteria
Year: 2022
Source: ECCO'22
Authors: ParoniPhD, M.(1);Leccese, G.(1);Ranzani, V.(2);Pagani, M.(3);Landini, P.(1);Vecchi, M.(4);Abrignani, S.(2);Facciotti, F.(5);Caprioli, F.(4);Geginat, J.(2);
Created: Friday, 11 February 2022, 3:56 PM
P706: Caracterization of de novo inflammatory bowel disease (IBD) diagnosed in immigrants migrating from low to high prevalence areas of IBD: a case-control study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gordillo J.*1, Torres P.2, García-García de Paredes A.3, Llaό J.4, Lόpez San Román A.3, Domènech E.2, Garcia-Planella E.1

Created: Wednesday, 20 February 2019, 10:36 AM
P706: Lower need for adalimumab dose intensification in IBD patients treated with combined immune suppression compared with adalimumab monotherapy
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Kovacs1*, B. Kadleckova2, L. Gombosova3, L. Novotna4, E. Barlova4, J. Lucenincova5, P. Mikus6, M. Zakuciova3, Z. Zelinkova1

Created: Thursday, 21 February 2019, 9:14 AM
P706: Monitoring asymptomatic patients with Crohn's disease: the role of intestinal ultrasound
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Dussias, N.(1)*;Melotti, L.(1);Mazzotta, E.(1);Decorato, A.(1);Vanigli, N.(1);Rizzello, F.(1);Gionchetti, P.(1);
Created: Friday, 14 July 2023, 11:12 AM
P706: Patient knowledge towards biological treatment in inflammatory bowel diseases: a cross-sectional survey
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Wiśniewska-Jarosińska*1, M. Włodarczyk2, A. Gąsiorowska1, J. Fichna3, A. Sobolewska-Włodarczyk1

Created: Friday, 22 February 2019, 9:41 AM
P707 Anti-TNFα therapy has no effect on bone mineral density in younger patients with inflammatory bowel disease: A single-centre observational study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Filip1,2, S. Jarmakiewicz - Czaja3, D. Piątek4, J. Sztembis5, A. Pękala1, W. Guz6

Created: Thursday, 30 January 2020, 10:12 AM
P707: 38 Weeks treatment of UC patients with different daily doses of mesalazine
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Laoun*1, R. Hofmann2

Created: Friday, 22 February 2019, 9:41 AM
P707: Increasing abundance of faecalibacterium prausnitzii is associated with decreased intestinal inflammation in Crohn’s disease: A longitudinal study
Year: 2018
Source: ECCO '18 Vienna
Authors:

O. Björkqvist1*, D. Repsilber2, M. Seifert3, L. Engstrand3, I. Rangel2, J. Halfvarson2

Created: Thursday, 21 February 2019, 9:14 AM
P707: Microbial signature of the colon is not associated with response to vedolizumab in Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: HagemanMD, I.(1,2);Joustra, V.(1);Li Yim, A.(2,3);Davids, M.(4);Henneman, P.(3);Hakvoort, T.(2);Probert, F.(5);Satsangi, J.(6);D'Haens, G.(1);De Jonge, W.(2);
Created: Friday, 11 February 2022, 3:56 PM
P707: Paediatric IBD patients do not meet the daily recommendations of vitamin D and calcium intake: survey based analysis in a tertiary centre
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Shergill-Bonner R., Zambrano Perez A., Acton N., Chadokufa S., Huggett B., Kiparissi F., Baycheva M., Shah N., Sider S.

Created: Wednesday, 20 February 2019, 10:36 AM
P707: Using urgent small bowel ultrasound (SBUS) as a tool for decision-making in patients with inflammatory bowel disease (IBD): retrospective analysis of United Kingdom (UK) patients' outcome.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lehmann, A.(1)*;Nandra, G.(2);Power, N.(2);Lindsay, J.O.(1);
Created: Friday, 14 July 2023, 11:12 AM
P708 The effect of psychotherapy on quality of life in inflammatory bowel disease patients: A systematic literature review
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Paulides1,2, I. Boukema2, C.J. van der Woude1, N.K.H. de Boer2

Created: Thursday, 30 January 2020, 10:12 AM
P708: Helicobacter pylori and IBD are inversely related, suggesting that individuals infected with the bacteria are less susceptible to the disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lichtenstein L.*1, Boltin D.1, Leibovici H.1, Tsadok Perets T.2, Avni I.1, Comaneshter D.3, Leibovici-Weissman Y.1, Cohen A.3, Niv Y.1,4, Levi Z.1,4

Created: Wednesday, 20 February 2019, 10:36 AM
P708: Home-based infusion therapy for biologic agent administration as a therapeutic option for patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Madden, S. S. R. Pulusu*, I. Lawrance

Created: Thursday, 21 February 2019, 9:14 AM
P708: Ileal involvement defined by Montreal classification in Crohn’s disease is associated with a distinct microbial composition in ileal and colonic mucosa
Year: 2022
Source: ECCO'22
Authors: Hernandez-Rocha, C.(1);Nayeri, S.(1);Turpin, W.(1);Borowski, K.(1);Stempak, J.(1);Silverberg, M.S.(1);
Created: Friday, 11 February 2022, 3:56 PM
P708: Post-COVID-19 and Quality of Life in Patients with Immune Mediated Inflammatory Diseases
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Schlosser, T.(1)*;Krasselt , M.(2);Elsing, L.(1);Hecker, M.(1);Holler, B.(1);Hoffmeister, A.(1);
Created: Friday, 14 July 2023, 11:12 AM
P708: Prospective study to predict psychological morbidity in young people with inflammatory bowel disease using novel risk assessment tool
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Hoogkamer*1, A. Brooks1, G. Rowse2, P. Norman2, A. Lobo1

Created: Friday, 22 February 2019, 9:41 AM
P709 Is azathioprine safe as long-term treatment in paediatric patients with inflammatory bowel disease?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.A. Martínez Ibeas, I. Bacelo Ruano, S. Rodríguez Manchón, M. Velasco Rodríguez-Belvís, J.F. Viada Bris, G. Domínguez Ortega, R.A. Muñoz Codoceo

Created: Thursday, 30 January 2020, 10:12 AM
P709: Distinct Pattern of Gut Microbial Dysbiosis in Crohn's Disease and Intestinal Tuberculosis - A Machine Learning-based classification model
Year: 2022
Source: ECCO'22
Authors: Markandey, M.(1);Bajaj, A.(1);Vuyyuru, S.K.(1);Mohta, S.(1);Singh, M.(1);Verma, M.(1);Kumar, S.(1);Kante, B.(1);Kumar, P.(1);Makharia, G.(1);Kedia, S.(1);Ahuja, V.(1);
Created: Friday, 11 February 2022, 3:56 PM
P709: Early measurement of serum cytokines as predictor of clinical and endoscopic outcome to vedolizumab in patients with ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Bertani*1, L. Antonioli2, L. Baglietto2, G. Tapete1, E. Albano1, M. G. Mumolo3, L. Ceccarelli3, S. Maltinti1, M. Fornai2, S. Marchi1, C. Blandizzi2, F. Costa3

Created: Friday, 22 February 2019, 9:41 AM